Bringing androgens up a NOTCH in breast cancer

Endocrine-Related Cancer

Volumn 21, Issue 4, 2014, Pages

  Tarulli, Gerard A ^a   Butler, Lisa M ^a   Tilley, Wayne D ^a   Hickey, Theresa E ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Androgen receptor; Breast; Hormone receptor; Mammary gland; Testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; NOTCH RECEPTOR; PROGESTERONE RECEPTOR; PROLACTIN RECEPTOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AR PROTEIN, HUMAN;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; CANCER GROWTH; CANCER RISK; CANCER SUSCEPTIBILITY; EPITHELIUM CELL; GENETIC ANALYSIS; HUMAN; MAMMARY GLAND FUNCTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; BREAST NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MAMMARY GLAND; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANDROGENS; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; RECEPTORS, ANDROGEN; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84905989960     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0248     Document Type: Review

References (196)

1. Agoff SN, Swanson PE, Linden H, Hawes SE & Lawton TJ 2003 Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations. American Journal of Clinical Pathology 120 725-731. (doi:10.1309/42F00D0DJD0J5EDT)
2. Al-Hussaini H, Subramanyam D, Reedijk M & Sridhar SS 2011 Notch signaling pathway as a therapeutic target in breast cancer. Molecular Cancer Therapeutics 10 9-15. (doi:10.1158/1535-7163.MCT-10-0677)
3. Alshenawy HA 2012 Prevalence of androgen receptors in invasive breast carcinoma and its relation with estrogen receptor, progesterone receptor and Her2/neu expression. Journal of the Egyptian National Cancer Institute 24 77-83. (doi:10.1016/j.jnci.2012.04.001)
4. Andersson ER, Sandberg R & Lendahl U 2011 Notch signaling: simplicity in design, versatility in function. Development 138 3593-3612. (doi:10.1242/dev.063610)
5. Armakolas A, Stathopoulos GP, Nezos A, Theos A, Stathaki M & Koutsilieris M 2012 Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients. Oncology Reports 28 2255-2263. (doi:10.3892/or.2012.2018)
6. Aupperlee MD, Leipprandt JR, Bennett JM, Schwartz RC & Haslam SZ 2013 Amphiregulin mediates progesterone-induced mammary ductal development during puberty. Breast Cancer Research 15 R44. (doi:10.1186/bcr3431)
7. Badders NM, Goel S, Clark RJ, Klos KS, Kim S, Bafico A, Lindvall C, Williams BO & Alexander CM 2009 The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage. PLoS ONE 4 e6594. (doi:10.1371/journal.pone.0006594.s008)
8. Baniwal SK, Little GH, Chimge N-O & Frenkel B 2012 Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation. Journal of Cellular Physiology 227 2276-2282. (doi:10.1002/jcp.22966)
9. Barbosa-Desongles A, Hernández C, Simó R & Selva DM 2013 Testosterone induces cell proliferation and cell cycle gene overexpression in human visceral preadipocytes. American Journal of Physiology. Cell Physiology 305 C355-C359. (doi:10.1152/ajpcell.00019.2013)
10. Belandia B & Parker MG 2006 Nuclear receptor regulation gears up another Notch. Nuclear Receptor Signaling 4 e001. (doi:10.1621/nrs.04001)
11. Belandia B, Powell SM, Garcia-Pedrero JM, Walker MM, Bevan CL & Parker MG 2005 Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Molecular and Cellular Biology 25 1425-1436. (doi:10.1128/MCB.25.4. 1425-1436.2005)
12. Beral V 1983 Parity and susceptibility to cancer. Ciba Foundation Symposium 96 182-203.
13. Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ & Tilley WD 1995 Androgens induce divergent proliferative responses in human breast cancer cell lines. Journal of Steroid Biochemistsry and Molecular Biology 52 459-467. (doi:10.1016/0960-0760(95)00005-K)
14. Bolós V, Mira E, Martínez-Poveda B, Luxán G, Cañamero M, Martínez-A C, Mañes S & de la Pompa JL 2013 Notch activation stimulates migration of breast cancer cells and promotes tumor growth. Breast Cancer Research 15 R54. (doi:10.1186/bcr3447)
15. Booth BW, Mack DL, Androutsellis-Theotokis A, McKay RDG, Boulanger CA & Smith GH 2008 The mammary microenvironment alters the differentiation repertoire of neural stem cells. PNAS 105 14891-14896. (doi:10.1073/pnas. 0803214105)
16. Boulanger CA, Bruno RD, Mack DL, Gonzales M, Castro NP, Salomon DS & Smith GH 2013 Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment. PLoS ONE 8 e62019. (doi:10.1371/journal.pone.0062019)
17. Bouras T, Pal B, Vaillant F, Harburg G, Asselin-Labat M-L, Oakes SR, Lindeman GJ & Visvader JE 2008 Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 3 429-441. (doi:10.1016/j.stem.2008.08.001)
18. Bray S & Furriols M 2001 Notch pathway: making sense of suppressor of hairless. Current Biology 11 R217-R221. (doi:10.1016/S0960-9822(01)00109-9)
19. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP & Weinberg RA 2000 Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes and Development 14 650-654. (doi:10.1101/gad.14.6.650)
20. Buono KD, Robinson GW, Martin C, Shi S, Stanley P, Tanigaki K, Honjo T & Hennighausen L 2006 The canonical Notch/RBP-J signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy. Developmental Biology 293 565-580. (doi:10.1016/j.ydbio.2006.02.043)
21. Burrell RA, McGranahan N, Bartek J & Swanton C 2013 The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501 338-345. (doi:10.1038/nature12625)
22. Casey RW & Wilson JD 1984 Antiestrogenic action of dihydrotestosterone in mouse breast. Competition with estradiol for binding to the estrogen receptor. Journal of Clinical Investigation 74 2272-2278. (doi:10.1172/JCI111654)
23. Chakrabarti R, Wei Y, Romano R-A, DeCoste C, Kang Y & Sinha S 2012 Elf5 regulates mammary gland stem/progenitor cell fate by influencing notch signaling. Stem Cells 30 1496-1508. (doi:10.1002/stem.1112)
24. Chang C, Lee SO, Yeh S & Chang TM 2013 Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver. Oncogene 33 3225-3234. (doi:10.1038/onc.2013. 274)
25. Chang TH-T, Kunasegaran K, Tarulli GA, De Silva D, Voorhoeve PM & Pietersen AM 2014 New insights into lineage restriction of mammary gland epithelium using parity-identified mammary epithelial cells. Breast Cancer Research 16 R1. (doi:10.1186/bcr3593)
26. Chazenbalk G, Singh P, Irge D, Shah A, Abbott DH & Dumesic DA 2013 Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation. Steroids 78 920-926. (doi:10.1016/j.steroids.2013.05. 001)
27. Cheng G 2004 Differential regulation of estrogen receptor (ER) and ER in primate mammary gland. Journal of Clinical Endocrinology and Metabolism 90 435-444. (doi:10.1210/jc.2004-0861)
28. Cheng XB, Jimenez M, Desai R, Middleton LJ, Joseph SR, Ning G, Allan CM, Smith JT, Handelsman DJ & Walters KA 2013 Characterizing the neuroendocrine and ovarian defects of androgen receptor-knockout female mice. American Journal of Physiology. Endocrinology and Metabolism 305 E717-E726. (doi:10.1152/ajpendo. 00263.2013)
29. Chillakuri CR, Sheppard D, Lea SM & Handford PA 2012 Notch receptor-ligand binding and activation: insights from molecular studies. Seminars in Cell & Developmental Biology 23 421-428. (doi:10.1016/j.semcdb. 2012.01.009)
30. Choudhury S, Almendro V, Merino VF, Wu Z, Maruyama R, Su Y, Martins FC, Fackler MJ, Bessarabova M, Kowalczyk A et al. 2013 Molecular profiling of human mammary gland links breast cancer risk to a p27(C) cell population with progenitor characteristics. Cell Stem Cell 13 117-130. (doi:10.1016/j.stem.2013. 05.004)
31. Cloke B & Christian M 2012 The role of androgens and the androgen receptor in cycling endometrium. Molecular and Cellular Endocrinology 358 166-175. (doi:10.1016/j.mce.2011.06.031)
32. Cohen B, Shimizu M, Izrailit J, Ng NFL, Buchman Y, Pan JG, Dering J & Reedijk M 2010 Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer. Breast Cancer Research and Treatment 123 113-124. (doi:10.1007/s10549-009-0621-9)
33. Colaluca IN, Tosoni D, Nuciforo P, Senic-Matuglia F, Galimberti V, Viale G, Pece S & Di Fiore PP 2008 NUMB controls p53 tumour suppressor activity. Nature 451 76-80. (doi:10.1038/nature06412)
34. Cunha GR, Young P, Hom YK, Cooke PS, Taylor JA & Lubahn DB 1997 Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. Journal of Mammary Gland Biology and Neoplasia 2 393-402. (doi:10.1023/A:1026303630843)
35. Dearth RK, Delgado DA, Hiney JK, Pathiraja T, Oesterreich S, Medina D, Dees WL & Lee AV 2010 Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer. Cancer Prevention Research 3 312-321. (doi:10.1158/1940-6207. CAPR-09-0074)
36. Descalzo SM & Arias AM 2012 The structure of Wntch signalling and the resolution of transition states in development. Seminars in Cell & Developmental Biology 23 443-449. (doi:10.1016/j.semcdb.2012.01.012)
37. Díaz Flaqué MC, Galigniana NM, Béguelin W, Vicario R, Proietti CJ, Cordo Russo R, Rivas MA, Tkach M, Guzmán P, Roa JC et al. 2013 Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy. Breast Cancer Research 15 R118. (doi:10.1186/bcr3587)
38. Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C & Gerald WL 2006 An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25 3994-4008. (doi:10.1038/sj.onc.1209415)
39. Dontu G & Wicha MS 2005 Survival of mammary stem cells in suspension culture: implications for stem cell biology and neoplasia. Journal of Mammary Gland Biology and Neoplasia 10 75-86. (doi:10.1007/s10911-005-2542-5)
40. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ & Wicha MS 2003 In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes and Development 17 1253-1270. (doi:10.1101/gad.1061803)
41. Dontu G, Jackson KW, McNicholas E, Kawamura MJ, Abdallah WM & Wicha MS 2004 Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Research 6 R605-R615. (doi:10.1186/bcr920)
42. Dürnberger H & Kratochwil K 1980 Specificity of tissue interaction and origin of mesenchymal cells in the androgen response of the embryonic mammary gland. Cell 19 465-471. (doi:10.1016/0092-8674(80)90521-8)
43. Eeckhoute J 2006 A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes and Development 20 2513-2526. (doi:10.1101/gad.1446006)
44. Eigeliene N, Elo T, Linhala M, Hurme S, Erkkola R & Harkonen P 2012 Androgens inhibit the stimulatory action of 17-estradiol on normal human breast tissue in explant cultures. Journal of Clinical Endocrinology and Metabolism 97 E1116-E1127. (doi:10.1210/jc.2011-3228)
45. Fang Z, Zhang T, Dizeyi N, Chen S, Wang H, Swanson KD, Cai C, Balk SP & Yuan X 2012 Androgen receptor enhances p27 degradation in prostate cancer cells through rapid and selective TORC2 activation. Journal of Biological Chemistry 287 2090-2098. (doi:10.1074/jbc.M111.323303)
46. Farmer P, Bonnefoi H, Becette V, Tubiana-Hulin M, Fumoleau P, Larsimont D, Macgrogan G, Bergh J, Cameron D, Goldstein D et al. 2005 Identification of molecular apocrine breast tumours by microarray analysis. Oncogene 24 4660-4671. (doi:10.1038/sj.onc.1208561)
47. Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, Anderson NG & Bundred NJ 2007 Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. Journal of the National Cancer Institute 99 616-627. (doi:10.1093/jnci/djk133)
48. Feng Y, Manka D, Wagner K-U & Khan SA 2007 Estrogen receptor-α expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. PNAS 104 14718-14723. (doi:10.1073/pnas.0706933104)
49. Fioretti FM, Sita-Lumsden A, Bevan CL & Brooke G 2014 Revising the role of the androgen receptor in breast cancer. Journal of Molecular Endocrinology 52 R257-R265. (doi:10.1530/JME-14-0030)
50. Fitzgerald K, Harrington A & Leder P 2000 Ras pathway signals are required for notch-mediated oncogenesis. Oncogene 19 4191-4198. (doi:10.1038/sj.onc.1203766)
51. Forsbach G, Güitrón-Cantú A, Vázquez-Lara J, Mota-Morales M & Díaz-Mendoza ML 2000 Virilizing adrenal adenoma and primary amenorrhea in a girl with adrenal hyperplasia. Archives of Gynecology and Obstetrics 263 134-136. (doi:10.1007/s004040050012)
52. Forster N, Saladi SV, van Bragt M, Sfondouris ME, Jones FE, Li Z & Ellisen LW 2014 Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1. Developmental Cell 28 147-160. (doi:10.1016/j.devcel. 2013.11.019)
53. Franks LM 1954 Latent carcinoma of the prostate. Journal of Pathology and Bacteriology 68 603-616. (doi:10.1002/path.1700680233)
54. Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G & Smith GH 1996 Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Research 56 1775-1785. (Pubitemid 26118213)
55. Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ, Konishi H, Konishi Y, Lauring J, Mohseni M et al. 2012 The growth response to androgen receptor signaling in ERa-negative human breast cells is dependent on p21 and mediated by MAPK activation. Breast Cancer Research 14 R27. (doi:10.1186/bcr3112)
56. Gasparini P, Fassan M, Cascione L, Guler G, Balci S, Irkkan C, Paisie C, Lovat F, Morrison C, Zhang J et al. 2014 Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options. PLoS ONE 9 e88525. (doi:10.1371/journal.pone.0088525. t003)
57. Geng Y, Yu Q, Sicinska E, Das M, Bronson RT & Sicinski P 2001 Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. PNAS 98 194-199. (doi:10.1073/pnas.011522998)
58. Graham JD, Mote PA, Salagame U, Balleine RL, Huschtscha LI & Clarke CL 2009 Hormone-responsive model of primary human breast epithelium. Journal of Mammary Gland Biology and Neoplasia 14 367-379. (doi:10.1007/s10911-009-9160-6)
59. Greeve MA, Allan RK, Harvey JM & Bentel JM 2004 Inhibition of MCF-7 breast cancer cell proliferation by 5α-dihydrotestosterone; a role for p21(Cip1/Waf1). Journal of Molecular Endocrinology 32 793-810. (doi:10.1677/jme.0.0320793)
60. Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M et al. 2006 Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Research 8 R56. (doi:10.1186/bcr1604)
61. Grimm SL, Seagroves TN, Kabotyanski EB, Hovey RC, Vonderhaar BK, Lydon JP, Miyoshi K, Hennighausen L, Ormandy CJ, Lee AV et al. 2002 Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Molecular Endocrinology 16 2675-2691. (doi:10.1210/me.2002-0239)
62. Grimshaw MJ, Cooper L, Papazisis K, Coleman JA, Bohnenkamp HR, Chiapero-Stanke L, Taylor-Papadimitriou J & Burchell JM 2008 Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Research 10 R52. (doi:10.1186/bcr2106)
63. Gu B, Watanabe K, Sun P, Fallahi M & Dai X 2013 Chromatin effector Pygo2 mediates Wnt-notch crosstalk to suppress luminal/alveolar potential of mammary stem and basal cells. Cell Stem Cell 13 48-61. (doi:10.1016/j.stem.2013. 04.012)
64. Gucalp A, Tolaney S, Isakoff SJ, Ingle JN, Liu MC, Carey LA, Blackwell K, Rugo H, Nabell L, Forero A et al. 2013 Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer. Clinical Cancer Research 19 5505-5512. (doi:10.1158/1078-0432. CCR-12-3327)
65. Hao L, Rizzo P, Osipo C, Pannuti A, Wyatt D, Cheung LW-K, Sonenshein G, Osborne BA & Miele L 2010 Notch-1 activates estrogen receptor-α- dependent transcription via IKKα in breast cancer cells. Oncogene 29 201-213. (doi:10.1038/onc.2009.323)
66. Haricharan S, Bainbridge MN, Scheet P & Brown PH 2014 Somatic mutation load of estrogen receptor-positive breast tumors predicts overall survival: an analysis of genome sequence data. Breast Cancer Research and Treatment 146 211-220. (doi:10.1007/s10549-014-2991-x)
67. Harrison H, Farnie G, Brennan KR & Clarke RB 2010a Breast cancer stem cells: something out of notching? Cancer Research 70 8973-8976. (doi:10.1158/0008-5472.CAN-10-1559)
68. Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, Bundred NJ & Clarke RB 2010b Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Research 70 709-718. (doi:10.1158/0008-5472.CAN-09-1681)
69. Haughian JM, Pinto MP, Harrell JC, Bliesner BS, Joensuu KM, Dye WW, Sartorius CA, Tan AC, Heikkilä P, Perou CM et al. 2012 Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch. PNAS 109 2742-2747. (doi:10.1073/pnas.1106509108)
70. Hewitt SC, Bocchinfuso WP, Zhai J, Harrell C, Koonce L, Clark J, Myers P & Korach KS 2002 Lack of ductal development in the absence of functional estrogen receptor α delays mammary tumor formation induced by transgenic expression of ErbB2/neu. Cancer Research 62 2798-2805. (Pubitemid 34525763)
71. Hickey TE, Robinson JLL, Carroll JS & Tilley WD 2012 Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene? Molecular Endocrinology 26 1252-1267. (doi:10.1210/me.2012-1107)
72. Hodgson MC, Vanostran G, Alghamdi S, Poppiti RJ, Agoulnik AI & Agoulnik IU 2013 Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice. PLoS ONE 8 e60455. (doi:10.1371/journal.pone.0060455)
73. Hsu FN, Yang MS, Lin E, Tseng CF & Lin H 2011 The significance of Her2 on androgen receptor protein stability in the transition of androgen requirement in prostate cancer cells. American Journal of Physiology. Endocrinology and Metabolism 300 E902-E908. (doi:10.1152/ajpendo.00610.2010)
74. Hu Y-C, Wang P-H, Yeh S, Wang R-S, Xie C, Xu Q, Zhou X, Chao H-T, Tsai M-Y & Chang C 2004 Subfertility and defective folliculogenesis in female mice lacking androgen receptor. PNAS 101 11209-11214. (doi:10.1073/pnas. 0404372101)
75. Hu C, Diévart A, Lupien M, Calvo E, Tremblay G & Jolicoeur P 2006 Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. American Journal of Pathology 168 973-990. (doi:10.2353/ajpath.2006.050416)
76. Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA & Tamimi RM 2011 Androgen receptor expression and breast cancer survival in postmenopausal women. Clinical Cancer Research 17 1867-1874. (doi:10.1158/1078-0432.CCR-10-2021)
77. Jayo MJ, Register TC, Hughes CL, Blas-Machado U, Sulistiawati E, Borgerink H & Johnson CS 2000 Effects of an oral contraceptive combination with or without androgen on mammary tissues: a study in rats. Journal of the Society for Gynecological Investigation 7 257-265. (doi:10.1016/S1071-5576(00) 00059-9)
78. Jhappan C, Gallahan D, Stahle C, Chu E, Smith GH, Merlino G & Callahan R 1992 Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes and Development 6 345-355. (doi:10.1101/gad.6.3.345)
79. Kannan N, Huda N, Tu L, Droumeva R, Aubert G, Chavez E, Brinkman RR, Lansdorp P, Emerman J, Abe S et al. 2013 The luminal progenitor compartment of the normal human mammary gland constitutes a unique site of telomere dysfunction. Stem Cell Reports 1 28-37. (doi:10.1016/j.stemcr.2013.04.003)
80. Kawaguchi H, Umekita Y, Fukuzaki K, Maeda H, Miyajima H, Nagata R & Yoshida H 2009 Expression of androgen receptor in mammary glands in ovariectomized cynomolgus monkeys. Veterinary Pathology 46 526-530. (doi:10.1354/vp.08-VP-0134-K-AM)
81. Kendrick H, Regan JL, Magnay F-A, Grigoriadis A, Mitsopoulos C, Zvelebil M & Smalley MJ 2008 Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 9 591. (doi:10.1186/1471-2164-9-591)
82. Kiaris H, Politi K, Grimm LM, Szabolcs M, Fisher P, Efstratiadis A & Artavanis-Tsakonas S 2004 Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium. American Journal of Pathology 165 695-705. (doi:10.1016/S0002-9440(10)63333-0)
83. Kim J, Villadsen R, Sørlie T, Fogh L, Grønlund SZ, Fridriksdottir AJ, Kuhn I, Rank F, Wielenga VT, Solvang H et al. 2012 Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. PNAS 109 6124-6129. (doi:10.1073/pnas.1203203109)
84. Kovacheva EL, Sinha Hikim AP, Shen R, Sinha I & Sinha-Hikim I 2010 Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin, c-Jun NH2-terminal kinase, Notch, and Akt signaling pathways. Endocrinology 151 628-638. (doi:10.1210/en.2009-1177)
85. Kramer WM & Rush BF 1973 Mammary duct proliferation in the elderley. Cancer 31 130-137. (doi:10.1002/1097-0142(197301)31:1〈130::AIDCN)
86. Kraus TS, Cohen C & Siddiqui MT 2010 Prostate-specific antigen and hormone receptor expression in male and female breast carcinoma. Diagnostic Pathology 5 63. (doi:10.1186/1746-1596-5-63)
87. Kuenen-Boumeester V, Van der Kwast TH, Claassen CC, Look MP, Liem GS, Klijn JG & Henzen-Logmans SC 1996 The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters. European Journal of Cancer 32A 1560-1565. (doi:10.1016/0959-8049(96)00112-8)
88. Lafkas D, Rodilla V, Huyghe M, Mourao L, Kiaris H & Fre S 2013 Notch3 marks clonogenic mammary luminal progenitor cells in vivo. Journal of Cell Biology 203 47-56. (doi:10.1083/jcb.201307046)
89. Lain AR, Creighton CJ & Conneely OM 2013 Research resource: progesterone receptor targetome underlying mammary gland branching morphogenesis. Molecular Endocrinology 27 1743-1761. (doi:10.1210/me.2013-1144)
90. Lamar CP & Rezek PR 1958 Testosterone pellet implants for advanced breast carcinomatosis in the female; preliminary report. Journal of the American Geriatrics Society 6 397-404.
91. LaMarca HL & Rosen JM 2008 Hormones and mammary cell fate - what will I become when I grow up? Endocrinology 149 4317-4321. (doi:10.1210/en.2008- 0450)
92. Lanzino M, Sisci D, Morelli C, Garofalo C, Catalano S, Casaburi I, Capparelli C, Giordano C, Giordano F, Maggiolini M et al. 2010 Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells - identification of a novel androgen response element. Nucleic Acids Research 38 5351-5365. (doi:10.1093/nar/gkq278)
93. Lanzino M, Maris P, Sirianni R, Barone I, Casaburi I, Chimento A, Giordano C, Morelli C, Sisci D, Rizza P et al. 2013 DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation. Cell Death & Disease 4 e724-e710. (doi:10.1038/cddis.2013.235)
94. Lavery DN, Villaronga MA, Walker MM, Patel A, Belandia B & Bevan CL 2011 Repression of androgen receptor activity by HEYL, a third member of the hairy/enhancer-of-split-related family of Notch effectors. Journal of Biological Chemistry 286 17796-17808. (doi:10.1074/jbc.M110.198655)
95. Lebbe M & Woodruff TK 2013 Involvement of androgens in ovarian health and disease. Molecular Human Reproduction 19 828-837. (doi:10.1093/molehr/ gat065)
96. Lee HJ & Ormandy CJ 2012 Interplay between progesterone and prolactin in mammary development and implications for breast cancer. Molecular and Cellular Endocrinology 357 101-107. (doi:10.1016/j.mce.2011.09.020)
97. Li S, Han B, Liu G, Li S, Ouellet J, Labrie F & Pelletier G 2010 Immunocytochemical localization of sex steroid hormone receptors in normal human mammary gland. Journal of Histochemistry and Cytochemistry 58 509-515. (doi:10.1369/jhc.2009.954644)
98. Liao M-J, Zhang CC, Zhou B, Zimonjic DB, Mani SA, Kaba M, Gifford A, Reinhardt F, Popescu NC, Guo W et al. 2007 Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Research 67 8131-8138. (doi:10.1158/0008-5472.CAN-06-4493)
99. Lim E, Wu D, Pal B, Bouras T, Asselin-Labat M-L, Vaillant F, Yagita H, Lindeman GJ, Smyth GK & Visvader JE 2010 Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Research 12 R21. (doi:10.1186/bcr2560)
100. Lindeman GJ, Visvader JE, Smalley MJ & Eaves CJ 2008 The future of mammary stem cell biology: the power of in vivo transplants. Breast Cancer Research 10 402 (author reply 403). (doi:10.1186/bcr1986)
101. Lindsay J, Jiao X, Sakamaki T, Casimiro MC, Shirley LA, Tran TH, Ju X, Liu M, Li Z, Wang C et al. 2008 ErbB2 induces Notch1 activity and function in breast cancer cells. Clinical and Translational Science 1 107-115. (doi:10.1111/j.1752-8062.2008.00041.x)
102. Ling H & Jolicoeur P 2013 Notch-1 signaling promotes the cyclinD1-dependent generation of mammary tumor-initiating cells that can revert to bi-potential progenitors from which they arise. Oncogene 32 3410-3419. (doi:10.1038/onc.2012.341)
103. Ling H, Sylvestre J-R & Jolicoeur P 2010 Notch1-induced mammary tumor development is cyclin D1-dependent and correlates with expansion of pre-malignant multipotent duct-limited progenitors. Oncogene 29 4543-4554. (doi:10.1038/onc.2010.186)
104. Ling H, Sylvestre JR & Jolicoeur P 2013 Cyclin D1-dependent induction of luminal inflammatory breast tumors by activated notch3. Cancer Research 73 5963-5973. (doi:10.1158/0008-5472.CAN-13-0409)
105. Liu X-H, Yao S, Levine AC, Kirschenbaum A, Pan J, Wu Y, Qin W, Collier L, Bauman WA & Cardozo CP 2012 Nandrolone, an anabolic steroid, stabilizes Numb protein through inhibition of mdm2 in C2C12 myoblasts. Journal of Andrology 33 1216-1223. (doi:10.2164/jandrol.112.016428)
106. Liu X-H, Wu Y, Yao S, Levine AC, Kirschenbaum A, Collier L, Bauman WA & Cardozo CP 2013 Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt/β-catenin signaling to T cell factor elements in the Numb promoter. Journal of Biological Chemistry 288 17990-17998. (doi:10.1074/jbc.M113.478487)
107. Lobo RA, Rosen RC, Yang HM, Block B & Van Der Hoop RG 2003 Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertility and Sterility 79 1341-1352. (doi:10.1016/S0015-0282(03)00358-3)
108. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Shyamala G, Conneely OM & O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes and Development 9 2266-2278. (doi:10.1101/gad.9.18.2266)
109. Lyu S, Yu Q, Ying G, Wang S, Wang Y, Zhang J & Niu Y 2014 Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer. International Journal of Oncology 44 229-237. (doi:10.3892/ijo.2013.2151)
110. Macias H & Hinck L 2012 Mammary gland development. Wiley Interdisciplinary Reviews. Developmental Biology 1 533-557. (doi:10.1002/wdev. 35)
111. Mazoujian G, Pinkus GS, Davis S & Haagensen DE 1983 Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. American Journal of Pathology 110 105-112. (Pubitemid 13147256)
112. Mazoujian G, Bodian C, Haagensen DE & Haagensen CD 1989 Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Cancer 63 2156-2161. (doi:10.1002/1097-0142(19890601)63:11〈2156::A)
113. Mazzone M, Selfors LM, Albeck J, Overholtzer M, Sale S, Carroll DL, Pandya D, Lu Y, Mills GB, Aster JC et al. 2010 Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. PNAS 107 5012-5017. (doi:10.1073/pnas.1000896107)
114. McNamara KM, Yoda T, Takagi K, Miki Y, Suzuki T & Sasano H 2013 Androgen receptor in triple negative breast cancer. Journal of Steroid Biochemistry and Molecular Biology 133 66-76. (doi:10.1016/j.jsbmb.2012.08.007)
115. Meier-Abt F, Milani E, Roloff T, Brinkhaus H, Duss S, Meyer DS, Klebba I, Balwierz PJ, van Nimwegen E & Bentires-Alj M 2013 Parity induces differentiation and reduces Wnt/ Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. Breast Cancer Research 15 R36. (doi:10.1186/bcr3419)
116. Mirochnik Y, Veliceasa D, Williams L, Maxwell K, Yemelyanov A, Budunova I & Volpert OV 2012 Androgen receptor drives cellular senescence. PLoS ONE 7 e31052. (doi:10.1371/journal.pone.0031052.s007)
117. Mukherjee A, Soyal SM, Li J, Ying Y, He B, DeMayo FJ & Lydon JP 2010 Targeting RANKL to a specific subset of murine mammary epithelial cells induces ordered branching morphogenesis and alveologenesis in the absence of progesterone receptor expression. FASEB Journal 24 4408-4419. (doi:10.1096/fj.10-157982)
118. Muller P 2002 The anti-estrogenic effect of all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on HES-1 expression. Journal of Biological Chemistry 277 28376-28379. (doi:10.1074/jbc.C200340200)
119. Mungamuri SK 2006 Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Research 66 4715-4724. (doi:10.1158/0008-5472.CAN-05-3830)
120. Muñoz-Descalzo S, de Navascues J & Arias AM 2012 Wnt-Notch signalling: an integrated mechanism regulating transitions between cell states. BioEssays 34 110-118. (doi:10.1002/bies.201100102)
121. Naderi A & Meyer M 2012 Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer. Breast Cancer Research 14 R111. (doi:10.1186/bcr3232)
122. Naderi A, Meyer M & Dowhan DH 2012 Cross-regulation between FOXA1 and ErbB2 signaling in estrogen receptor-negative breast cancer. Neoplasia 14 283-296. (doi:10.1593/neo.12294)
123. Nahleh Z 2008 Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory. Future Oncology 4 15-21. (doi:10.2217/14796694.4.1.15)
124. Naylor MJ, Lockefeer JA, Horseman ND & Ormandy CJ 2003 Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism. Endocrine 20 111-114. (doi:10.1385/ENDO:20:1-2:111)
125. Ni M, Chen Y, Lim E, Wimberly H, Bailey ST, Imai Y, Rimm DL, Liu XS & Brown M 2011 Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer Cell 20 119-131. (doi:10.1016/j.ccr.2011.05.026)
126. Obr AE, Grimm SL, Bishop KA, Pike JW, Lydon JP & Edwards DP 2013 Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. Molecular Endocrinology 27 1808-1824. (doi:10.1210/me.2013- 1077)
127. Oesterreich S & Davidson NE 2013 The search for ESR1 mutations in breast cancer. Nature Genetics 45 1415-1416. (doi:10.1038/ng.2831)
128. Ogawa Y, Hai E, Matsumoto K, Ikeda K, Tokunaga S, Nagahara H, Sakurai K, Inoue T & Nishiguchi Y 2008 Androgen receptor expression in breast cancer:
129. O'Reilly MW, Taylor AE, Crabtree NJ, Hughes BA, Capper F, Crowley RK, Stewart PM, Tomlinson JW & Arlt W 2014 Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. Journal of Clinical Endocrinology and Metabolism 99 1027-1036. (doi:10.1210/jc.2013-3399)
130. Ormandy CJ, Clarke CL, Kelly PA & Sutherland RL 1992 Androgen regulation of prolactin-receptor gene expression in MCF-7 and MDA-MB-453 human breast cancer cells. International Journal of Cancer. Journal International du Cancer 50 777-782. (doi:10.1002/ijc.2910500519)
131. Ormandy CJ, Hall RE, Manning DL, Robertson JF, Blamey RW, Kelly PA, Nicholson RI & Sutherland RL 1997 Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. Journal of Clinical Endocrinology and Metabolism 82 3692-3699. (Pubitemid 27509357)
132. Ormandy CJ, Naylor M, Harris J, Robertson F, Horseman ND, Lindeman GJ, Visvader J & Kelly PA 2003 Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Progress in Hormone Research 58 297-323. (doi:10.1210/rp.58.1.297)
133. Ortmann J, Prifti S, Bohlmann MK, Rehberger-Schneider S, Strowitzki T & Rabe T 2002 Testosterone and 5α-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Gynecological Endocrinology 16 113-120. (doi:10.1080/713603030)
134. Ousset M, Van Keymeulen A, Bouvencourt G, Sharma N, Achouri Y, Simons BD & Blanpain C 2012 Multipotent and unipotent progenitors contribute to prostate postnatal development. Nature Cell Biology 14 1131-1138. (doi:10.1038/ncb2600)
135. Pandya K, Meeke K, Clementz AG, Rogowski A, Roberts J, Miele L, Albain KS & Osipo C 2011 Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. British Journal of Cancer 105 796-806. (doi:10.1038/bjc.2011.321)
136. Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW & Lee KS 2011 Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers. Annals of Oncology 22 1755-1762. (doi:10.1093/annonc/mdq678)
137. Pashko LL, Schwartz AG, Abou-Gharbia M & Swern D 1981 Inhibition of DNA synthesis in mouse epidermis and breast epithelium by dehydroepiandrosterone and related steroids. Carcinogenesis 2 717-721. (doi:10.1093/carcin/2.8.717)
138. Pece S 2004 Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. Journal of Cell Biology 167 215-221. (doi:10.1083/jcb.200406140)
139. Peters AA, Buchanan G, Ricciardelli C, Bianco-Miotto T, Centenera MM, Harris JM, Jindal S, Segara D, Jia L, Moore NL et al. 2009 Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer. Cancer Research 69 6131-6140. (doi:10.1158/0008-5472.CAN-09-0452)
140. Peters AA, Ingman WV, Tilley WD & Butler LM 2011 Differential effects of exogenous androgen and an androgen receptor antagonist in the periand postpubertal murine mammary gland. Endocrinology 152 3728-3737. (doi:10.1210/en.2011-1133)
141. Pinto CA, Widodo E, Waltham M & Thompson EW 2013 Breast cancer stem cells and epithelial mesenchymal plasticity - implications for chemoresistance. Cancer Letters 341 56-62. (doi:10.1016/j.canlet.2013.06.003)
142. Plaks V, Brenot A, Lawson DA, Linnemann JR, Van Kappel EC, Wong KC, de Sauvage F, Klein OD & Werb Z 2013 Lgr5-expressing cells are sufficient and necessary for postnatal mammary gland organogenesis. Cell Reports 3 70-78. (doi:10.1016/j.celrep.2012.12.017)
143. Pozzobon A 2012 Androgen-modulated p21 and p53 gene expression in human non-transformed epithelial prostatic cells in primary cultures. International Journal of Molecular Medicine 30 967-973. (doi:10.3892/ijmm.2012.1082)
144. Quaynor SD, Stradtman EW Jr, Kim H-G, Shen Y, Chorich LP, Schreihofer DA & Layman LC 2013 Delayed puberty and estrogen resistance in a woman with estrogen receptor a variant. New England Journal of Medicine 369 164-171. (doi:10.1056/NEJMoa1303611)
145. Raafat A, Lawson S, Bargo S, Klauzinska M, Strizzi L, Goldhar AS, Buono K, Salomon D, Vonderhaar BK & Callahan R 2008 Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis. Oncogene 28 219-230. (doi:10.1038/onc.2008.379)
146. Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, Iscove N, Jones S, McKinney S, Emerman J et al. 2008 Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 3 109-118. (doi:10.1016/j.stem.2008.05.018)
147. Recchia AG, Musti AM, Lanzino M, Panno ML, Turano E, Zumpano R, Belfiore A, Andò S & Maggiolini M 2009 A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells. International Journal of Biochemistry & Cell Biology 41 603-614. (doi:10.1016/j.biocel.2008.07.004)
148. Ren Q, Zhang L, Ruoff R, Ha S, Wang J, Jain S, Reuter V, Gerald W, Giri DD, Melamed J et al. 2013 Expression of androgen receptor and its phosphorylated forms in breast cancer progression. Cancer 119 2532-2540. (doi:10.1002/cncr. 28092)
149. Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl P-O & Hedenfalk I 2009 Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer. Breast Cancer Research and Treatment 122 315-324. (doi:10.1007/s10549- 009-0568-x)
150. Rios AC, Fu NY, Lindeman GJ & Visvader JE 2014 In situ identification of bipotent stem cells in the mammary gland. Nature 506 322-327. (doi:10.1038/nature12948)
151. Rizzo P, Miao H, D'Souza G, Osipo C, Yun J, Zhao H, Mascarenhas J, Wyatt D, Antico G, Hao L et al. 2008 Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Research 68 5226-5235. (doi:10.1158/0008-5472.CAN-07-5744)
152. Robinson GW, McKnight RA, Smith GH & Hennighausen L 1995 Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121 2079-2090.
153. Robinson GW, Smith GH, Gallahan D, Zimmer A, Furth PA & Hennighausen L 1996 Understanding mammary gland development through the imbalanced expression of growth regulators. Developmental Dynamics 206 159-168. (doi:10.1002/(SICI) 1097-0177(199606)206:2〈159)
154. Robinson JLL, MacArthur S, Ross-Innes CS, Tilley WD, Neal DE, Mills IG & Carroll JS 2011 Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO Journal 30 3019-3027. (doi:10.1038/emboj.2011.216)
155. Rose C, Kamby C, Mouridsen HT, Andersson M, Bastholt L, Møller KA, Andersen J, Munkholm P, Dombernowsky P & Christensen IJ 2000 Combined endocrine treatment of elderly postmenopausal patients with metastatic breast cancer. A randomized trial of tamoxifen vs. tamoxifen+aminoglutethimide and hydrocortisone and tamoxifen+ fluoxymesterone in women above 65 years of age. Breast Cancer Research and Treatment 61 103-110. (doi:10.1023/A:1006460925986)
156. Russo J, Moral R, Balogh GA, Mailo D & Russo IH 2005 The protective role of pregnancy in breast cancer. Breast Cancer Research 7 131-142. (doi:10.1186/bcr1029)
157. Ryan J, Burger HG, Szoeke C, Lehert P, Ancelin M-L, Henderson VW & Dennerstein L 2009 A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women. Menopause 16 509-517. (doi:10.1097/gme.0b013e31818d635f)
158. Šale S, Lafkas D & Artavanis-Tsakonas S 2013 Notch2 genetic fate mapping reveals two previously unrecognized mammary epithelial lineages. Nature Cell Biology 15 451-460. (doi:10.1038/ncb2725)
159. Sampayo R, Recouvreux S & Simian M 2013 The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer. Vitamins and Hormones 93 185-201. (doi:10.1016/ B978-0-12-416673-8.00012-5)
160. Santagata S, Thakkar A, Ergonul A, Wang B, Woo T, Hu R, Harrell JC, McNamara G, Schwede M, Culhane AC et al. 2014 Taxonomy of breast cancer based on normal cell phenotype predicts outcome. Journal of Clinical Investigation 124 859-870. (doi:10.1172/JCI70941DS1)
161. Schiewer MJ, Morey LM, Burd CJ, Liu Y, Merry DE, Ho S-M & Knudsen KE 2008 Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer. Oncogene 28 1016-1027. (doi:10.1038/onc.2008.446)
162. Secreto G, Venturelli E, Meneghini E, Carcangiu ML, Paolini B, Agresti R, Pellitteri C, Berrino F, Gion M, Cogliati P et al. 2012 Androgen receptors and serumtestosteronelevels identify different subsets ofpostmenopausal breast cancers. BMC Cancer 12 1-1. (doi:10.1186/1471-2407-12-599)
163. Sen A, Prizant H, Light A, Biswas A, Hayes E, Lee H-J, Barad D, Gleicher N & Hammes SR 2014 Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression. PNAS 111 3008-3013. (doi:10.1073/pnas.1318978111)
164. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat M-L, Wu L, Lindeman GJ & Visvader JE 2006 Generation of a functional mammary gland from a single stem cell. Nature Cell Biology 439 84-88. (doi:10.1038/nature04372)
165. Shi P1, Zhang Y, Tong X, Yang Y & Shao Z 2011 Dihydrotestosterone induces p27 degradation via direct binding with SKP2 in ovarian and breast cancer. International Journal of Molecular Medicine 28 109-114. (doi:10.3892/ijmm.2011.677)
166. Shifren JL 2002 Androgen deficiency in the oophorectomized woman. Fertility and Sterility 77 (Suppl 4) S60-S62. (doi:10.1016/S0015-0282(02)02970- 9)
167. Shiina H, Matsumoto T, Sato T, Igarashi K, Miyamoto J, Takemasa S, Sakari M, Takada I, Nakamura T, Metzger D et al. 2006 Premature ovarian failure in androgen receptor-deficient mice. PNAS 103 224-229. (doi:10.1073/pnas. 0506736102)
168. Simanainen U, Gao YR, Walters KA, Watson G, Desai R, Jimenez M & Handelsman DJ 2012 Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors. Hormones & Cancer 3 113-124. (doi:10.1007/s12672-012-0107-9)
169. Simmons MJ, Serra R, Hermance N & Kelliher MA 2012 NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumor sphere-forming activity in vitro. Breast Cancer Research 14 R126. (doi:10.1186/bcr3321)
170. Siwko SK, Dong J, Lewis MT, Liu H, Hilsenbeck SG & Li Y 2008 Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cellsimplications for pregnancy-induced protection against breast cancer. Stem Cells 26 3205-3209. (doi:10.1634/ stemcells.2008-0103)
171. Smith GH 1996 Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Research and Treatment 39 21-31. (doi:10.1007/ BF01806075)
172. Smith GI, Yoshino J, Reeds DN, Bradley D, Burrows RE, Heisey HD, Moseley AC & Mittendorfer B 2014 Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 99 256-265. (doi:10.1210/jc.2013-2835)
173. Ström A, Arai N, Leers J & Gustafsson JA 2000 The hairy and enhancer of split homologue-1 (HES-1) mediates the proliferative effect of 17β-estradiol on breast cancer cell lines. Oncogene 19 5951-5953. (doi:10.1038/sj.onc.1203990)
174. Stute P, Sielker S, Wood CE, Register TC, Lees CJ, Dewi FN, Williams JK, Wagner JD, Stefenelli U & Cline JM 2011 Life stage differences in mammary gland gene expression profile in non-human primates. Breast Cancer Research and Treatment 133 617-634. (doi:10.1007/s10549-011-1811-9)
175. Stylianou S 2006 Aberrant activation of notch signaling in human breast cancer. Cancer Research 66 1517-1525. (doi:10.1158/0008-5472.CAN-05-3054)
176. Sultana A, Idress R, Naqvi ZA, Azam I, Khan S, Siddiqui AA & Lalani E-N 2014 Expression of the androgen receptor, pAkt, and pPTEN in breast cancer and their potential in prognostication. Translational Oncology 7 355-362. (doi:10.1016/j.tranon.2014.04.004)
177. Tao L, Roberts AL, Dunphy KA, Bigelow C, Yan H & Jerry DJ 2011 Repression of mammary stem/progenitor cells by p53 is mediated by notch and separable from apoptotic activity. Stem Cells 29 119-127. (doi:10.1002/stem.552)
178. Tarulli GA, De Silva D, Ho V, Kunasegaran K, Ghosh K, Tan BC, Bulavin DV & Pietersen AM2013 Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium. Breast Cancer Research 15 R10. (doi:10.1186/bcr3381)
179. Thomas AN, Gordan GS, Goldman L & Lowe R 1962 Antitumor efficacy of 2α-methyl dihydrotestosterone propionate in advanced breast cancer. Cancer 15 176-178. (doi:10.1002/1097-0142(196201/02)15:1〈176::AI)
180. Tian Y, Chen B, Guan P, Kang Y & Lu Z 2013 A prognosis classifier for breast cancer based on conserved gene regulation between mammary gland development and tumorigenesis: a multiscale statistical model. PLoS ONE 8 e60131. (doi:10.1371/journal.pone.0060131.s008)
181. Tormey DC, Lippman ME, Edwards BK & Cassidy JG 1983 Evaluation of tamoxifen doses with and without fluoxymesterone in advanced breast cancer. Annals of Internal Medicine 98 139-144. (doi:10.7326/0003-4819-98-2-139)
182. Toy W, Shen Y, Won H, Green B, Sakr RA, Will M, Li Z, Gala K, Fanning S, King TA et al. 2013 ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nature Genetics 45 1439-1445. (doi:10.1038/ng.2822)
183. Tsang JY, Ni YB, Chan SK, Shao MM, Law BK, Tan PH & Tse GM 2014 Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers. Annals of Surgical Oncology 21 2218-2228. (doi:10.1245/s10434-014-3629-2)
184. Valdez JM, Zhang L, Su Q, Dakhova O, Zhang Y, Shahi P, Spencer DM, Creighton CJ, Ittmann MM & Xin L 2012 Notch and TGFβ form a reciprocal positive regulatory loop that suppresses murine prostate basal stem/progenitor cell activity. Cell Stem Cell 11 676-688. (doi:10.1016/j.stem.2012.07.003)
185. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J, Sharma N, Dekoninck S & Blanpain C 2011 Distinct stem cells contribute to mammary gland development and maintenance. Nature 479 189-193. (doi:10.1038/nature10573)
186. Walters KA, Allan CM, Jimenez M, Lim PR, Davey RA, Zajac JD, Illingworth P & Handelsman DJ 2007 Female mice haploinsufficient for an inactivated androgen receptor (AR) exhibit age-dependent defects that resemble the AR null phenotype of dysfunctional late follicle development, ovulation, and fertility. Endocrinology 148 3674-3684. (doi:10.1210/en.2007-0248)
187. Walters KA, McTavish KJ, Seneviratne MG, Jimenez M, McMahon AC, Allan CM, Salamonsen LA & Handelsman DJ 2009 Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function. Endocrinology 150 3274-3282. (doi:10.1210/en.2008-1750)
188. Walters KA, Simanainen U & Handelsman DJ 2010 Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Human Reproduction Update 16 543-558. (doi:10.1093/humupd/dmq003)
189. Watts NB, Notelovitz M, Timmons MC, Addison WA, Wiita B & Downey LJ 1995 Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause. Obstetrics and Gynecology 85 529-537. (doi:10.1016/0029-7844(94) 00448-M)
190. Wood CE, Lees CJ & Cline JM 2009 Mammary gland and endometrial effects of testosterone in combination with oral estradiol and progesterone. Menopause 16 466-476. (doi:10.1097/gme.0b013e318191747a)
191. Xie B, Tsao SW & Wong YC 2000 Sex hormone-induced mammary carcinogenesis in the female Noble rats: expression of bcl-2 and bax in hormonal mammary carcinogenesis. Breast Cancer Research and Treatment 61 45-57. (doi:10.1023/A:1006400732154)
192. Yalcin-Ozuysal O, Fiche M, Guitierrez M, Wagner K-U, Raffoul W & Brisken C 2010 Antagonistic roles of Notch and p63 in controlling mammary epithelial cell fates. Cell Death and Differentiation 17 1600-1612. (doi:10.1038/cdd.2010.37)
193. Yeh S 2003 Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor. Journal of Experimental Medicine 198 1899-1908. (doi:10.1084/jem.20031233)
194. Yun J, Pannuti A, Espinoza I, Zhu H, Hicks C, Zhu X, Caskey M, Rizzo P, Souza GDA, Backus K et al. 2013 Crosstalk between PKCa and Notch-4 in endocrine-resistant breast cancer cells. Oncogene 2 e60-e12. (doi:10.1038/oncsis.2013.26)
195. Zarrouf FA, Artz S, Griffith J, Sirbu C & Kommor M 2009 Testosterone and depression: systematic review and meta-analysis. Journal of Psychiatric Practice 15 289-235. (doi:10.1097/01.pra.0000358315.88931.fc)
196. Zhou J, Ng S, Adesanya-Famuiya O, Anderson K & Bondy CA 2000 Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB Journal 14 1725-1730. (doi:10.1096/fj.99-0863com)